Related Experiment Video
Updated: Jan 7, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Perinatal Management of Andersen-Tawil Syndrome Using a Wearable Cardioverter-Defibrillator: A Case Report
Yuta Sakaguchi1, Sou Otsuki1, Daisuke Izumi2
1Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Andersen-Tawil syndrome (ATS) in pregnancy is rare. Combined medication and a wearable cardioverter-defibrillator (WCD) safely managed arrhythmias, ensuring positive maternal and fetal outcomes.
Area of Science:
- Cardiology
- Genetics
- Obstetrics
Background:
- Andersen-Tawil syndrome (ATS), or congenital long QT syndrome type 7 (LQT7), is a rare inherited channelopathy.
- It is caused by KCNJ2 mutations and presents with ventricular arrhythmias, periodic paralysis, and dysmorphic features.
- Pregnancy in women with ATS is uncommon, and management strategies are not well-defined.
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy VI: Nursing Management

